Your Shopping Cart is empty.


Download sample
File Details
Published: 2017-05-18 00:32:24.490150 Category: Drugs and Pills Type: Illustration Model release: No
Share
       

Sclerostin (murine) protein. Causes decreased bone formation by inhibiting the Wnt signaling pathway. Target of romosozumab, a monoclonal antibody for the treatment of osteoporosis.

Contributor: molekuul.be
ID : 153241862
TitleFilesize
Illustration4096x3760


Buy on Adobe Stock
Keywords
bone, growth, regulator, gene, signalling, pathway, disease, osteoporosis, structure, peptide, protein, amino, acid, molecular, polymer, atom, science, scientific, health, molecular, model, white background


Related items